Literature DB >> 9734120

Lipodystrophia with protease inhibitors in HIV patients.

P Massip1, B Marchou, E Bonnet, L Cuzin, J L Montastruc.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9734120

Source DB:  PubMed          Journal:  Therapie        ISSN： 0040-5957            Impact factor:   2.070


× No keyword cloud information.
  4 in total

Review 1.  Hormonal contraception and HIV-positive women: metabolic concerns and management strategies.

Authors:  Julie Womack; Susan Richman; Phyllis C Tien; Margaret Grey; Ann Williams
Journal:  J Midwifery Womens Health       Date:  2008 Jul-Aug       Impact factor: 2.388

Review 2.  Metabolic complications associated with HIV protease inhibitor therapy.

Authors:  David Nolan
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Proposed ratios and cutoffs for the assessment of lipodystrophy in HIV-seropositive individuals.

Authors:  R A Beraldo; H S Vassimon; D C Aragon; A M Navarro; F J Albuquerque de Paula; M C Foss-Freitas
Journal:  Eur J Clin Nutr       Date:  2014-07-30       Impact factor: 4.016

4.  HIV-associated adipose redistribution syndrome (HARS): definition, epidemiology and clinical impact.

Authors:  Kenneth Lichtenstein; Ashok Balasubramanyam; Rajagopal Sekhar; Eric Freedland
Journal:  AIDS Res Ther       Date:  2007-07-16       Impact factor: 2.250
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.